Cash & equivalents increased 145.9%
Cash & equivalents changed +145.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +145.9% from the comparable as-filed period.
Gross margin changed +4685 basis points from the comparable as-filed period.
Gross profit changed +899.3% from the comparable as-filed period.
Net income changed +1398.3% from the comparable as-filed period.
Operating income changed +1436.1% from the comparable as-filed period.
Operating margin changed +5705 basis points from the comparable as-filed period.
Research & development changed +36.4% from the comparable as-filed period.
Revenue changed +345.7% from the comparable as-filed period.
Selling, general & administrative changed +28.0% from the comparable as-filed period.
Stock-based compensation changed +29.7% from the comparable as-filed period.
Inventory changed -1.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.